BNF 72 (British National Formulary September 2016-March 2017) by Joint Formulary Committee

Skip to product information
1 of 1

BNF 72 (British National Formulary September 2016-March 2017) by Joint Formulary Committee

Regular price $10.00
Condition - Like New
1 In stock
Regular price $10.00
Condition - Like New
1 In stock
Select Condition

Free shipping in 12-14 business days on orders over $15

Summary

The September 2016 British National Formulary (BNF 72) is your essential reference book for prescribing, dispensing, and administering medicines.

The feel-good place to buy books
  • Free shipping in the US over $15
  • Supporting authors with AuthorSHARE
  • 100% recyclable packaging
  • Proud to be a B Corp – A Business for good
  • Sell-back with World of Books - Sell your Books

BNF 72 (British National Formulary September 2016-March 2017) by Joint Formulary Committee

The September 2016 British National Formulary (BNF 72) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. BNF 72 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next. Some of the significant content updates for BNF 72 include: New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid Updated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancer New drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetine Updated pregnancy-prevention advice for patients taking mycophenolate mofetil Updated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors, and pomalidomide Advice about the risk of ulceration with nicorandil treatment NICE guidelines including the use of vedolizumab for treating moderately to severely active Crohn’s disease New guidance on suspected or confirmed drug allergy Evidence grading of BNF recommendations.
SKU GOR010472164
ISBN 13 9780857112736
ISBN 10 0857112732
Title BNF 72 (British National Formulary September 2016-March 2017)
Author Joint Formulary Committee
Series British National Formulary
Condition Like New
Binding Type Paperback
Publisher Pharmaceutical Press
Year published 2016-09-21
Number of pages 1472
Cover note Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
Note The book has been read, but looks new. The book cover has no visible wear, and the dust jacket is included if applicable. No missing or damaged pages, no tears, possible very minimal creasing, no underlining or highlighting of text, and no writing in the margins